Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects
NCT02182323
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BI 201335 NA
DRUG:
Placebo solution
Sponsor
Boehringer Ingelheim